Roberta Lotti

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Neurotrophins and Their Receptors Stimulate Melanoma Cell Proliferation and Migration

Francesca Truzzi, Alessandra Marconi, Roberta Lotti et al. · Journal of Investigative Dermatology · 2008 · 169 citations · Full text

Tumor Innervation, Medicine, Melanoma +8

Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis

Sergei A. Grando, Jean‐Claude Bystryn, Alexander I. Chernyavsky et al. · Experimental Dermatology · 2009 · 133 citations · Full text

Apoptosis, Immunology, Cell Death +18

Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex

Peter Schäfer, Francesca Truzzi, Anastasia Parton et al. · Cellular Signalling · 2016 · 119 citations · Full text

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Piero Clavario, Vincenzo De Marzo, Roberta Lotti et al. · International Journal of Cardiology · 2021 · 114 citations · Full text